# Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia

> **NCT00538564** · PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Sickle Cell Anemia
- Priapism

## Interventions

- **DRUG:** tadalafil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00538564
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Trial closed just prior to study receiving Investigational Review Board approval
- **Last updated:** 2016-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538564, "Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00538564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*